This intellectual property portfolio showcases a diverse array of cutting-edge organoid technologies that are revolutionizing research and drug discovery across various fields. These inventions include advanced models for studying neurology, cancer, immunology, and gastrointestinal disorders, as well as innovative engineering and culture methods that enable the creation of more sophisticated and physiologically relevant organoid systems. By leveraging these technologies, researchers can gain unprecedented insights into disease mechanisms, accelerate the development of targeted therapies, and ultimately improve patient outcomes.
This collection features inventions from Stanford's pioneering researchers such as Sergiu Pasca, Paul George, Arash Alizadeh, Mark Davis, Calvin Kuo, Sarah Heilshorn, and Karl Deisseroth.